Provided by Tiger Fintech (Singapore) Pte. Ltd.

Chimerix

8.44
-0.0250-0.30%
Volume:5.59M
Turnover:47.09M
Market Cap:758.61M
PE:-8.99
High:8.44
Open:8.43
Low:8.42
Close:8.46
Loading ...

Update: Truist Raises PT on Jazz Pharmaceuticals to $230 From $220 on Heels of Announced Purchase of Chimerix, Keeps Buy Rating

MT Newswires Live
·
46 mins ago

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio

Zacks
·
Yesterday

Chimerix Cut to Hold From Buy by Jones Trading

Dow Jones
·
Yesterday

Chimerix Stock Hold Rating: Limited Upside Due to Acquisition Offer Price Alignment

TIPRANKS
·
Yesterday

Strategic Acquisition and NDA Submission Boost Chimerix’s Market Potential

TIPRANKS
·
Yesterday

Jazz Pharma Seen Poised to Do More Deals -- Market Talk

Dow Jones
·
Yesterday

Strategic Acquisition of Chimerix Enhances Jazz Pharmaceuticals’ Oncology Portfolio and Supports Buy Rating

TIPRANKS
·
Yesterday

Cautious Outlook on Chimerix Amid Acquisition and Uncertainties in Drug Approval

TIPRANKS
·
Yesterday

Chimerix deal represents ‘clear strategic fit’ for Jazz, says Stifel

TIPRANKS
·
Yesterday

Chimerix downgraded to Hold from Buy at Jefferies

TIPRANKS
·
Yesterday

CrowdStrike reports Q4 beat, Jazz to acquire Chimerix: Morning Buzz

TIPRANKS
·
Yesterday

Chimerix Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Yesterday

Chimerix a Prime Acquisition Candidate for Jazz Pharmaceuticals Due to Dordaviprone, Wedbush Says

MT Newswires Live
·
05 Mar

Hold Rating Issued Amidst Chimerix Acquisition by Jazz Pharmaceuticals

TIPRANKS
·
05 Mar

Strategic Acquisition: Jazz Pharmaceuticals’ Buy Rating Boosted by Chimerix Deal and Dordaviprone’s Market Potential

TIPRANKS
·
05 Mar

Chimerix downgraded to Neutral from Buy at H.C. Wainwright

TIPRANKS
·
05 Mar